These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23917476)

  • 41. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
    Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From Multiple Daily Injections to Hybrid Closed-Loop System in Ten Days, Utilizing a Structured Initiation Protocol.
    Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
    J Diabetes Sci Technol; 2020 May; 14(3):689-690. PubMed ID: 31876178
    [No Abstract]   [Full Text] [Related]  

  • 48. People with Type Diabetes Mellitus (T1DM) self-reported views on their own condition management reveal links to potentially improved outcomes and potential areas for service improvement.
    Stedman M; Rea R; Duff CJ; Livingston M; McLoughlin K; Wong L; Brown S; Grady K; Gadsby R; Paisley A; Fryer AA; Heald AH
    Diabetes Res Clin Pract; 2020 Dec; 170():108479. PubMed ID: 33002551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monthly Video-Consultation for Children With Type 1 Diabetes Using a Continuous Glucose Monitoring System: Design of ViDiKi, a Multimethod Intervention Study to Evaluate the Benefit of Telemedicine.
    Frielitz FS; Müller-Godeffroy E; Hübner J; Eisemann N; Dördelmann J; Menrath I; Katalinic A; Hiort O; von Sengbusch S
    J Diabetes Sci Technol; 2020 Jan; 14(1):105-111. PubMed ID: 31315446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge.
    Thomakos P; Vazeou A; Sakkas D; Panagopoulos G; Anifantakis K; Smyrnaki P; Arvanitaki T; Kyrlaki E; Kefalogiannis N; Mamoulakis D; Pappas A; Mitrakou A
    QJM; 2018 Sep; 111(9):629-633. PubMed ID: 29939323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Beneficial Effect of the Mobile Application
    Chatzakis C; Floros D; Papagianni M; Tsiroukidou K; Kosta K; Vamvakis A; Koletsos N; Hatziagorou E; Tsanakas I; Mastorakos G
    Diabetes Technol Ther; 2019 Nov; 21(11):627-634. PubMed ID: 31335204
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.
    Deiss D; Kordonouri O; Hartmann R; Hopfenmüller W; Lüpke K; Danne T
    Pediatr Diabetes; 2007 Jun; 8(3):157-62. PubMed ID: 17550426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of continuous glucose monitoring system in the management of severe hypoglycemia.
    Ryan EA; Germsheid J
    Diabetes Technol Ther; 2009 Oct; 11(10):635-9. PubMed ID: 19821755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
    ; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
    N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial.
    Haas J; Persson M; Brorsson AL; Toft EH; Olinder AL
    Trials; 2017 Nov; 18(1):562. PubMed ID: 29178923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.
    Polonsky WH; Hessler D
    Diabetes Technol Ther; 2013 Apr; 15(4):295-301. PubMed ID: 23427866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A person-centered education for adolescents with type 1 diabetes-A randomized controlled trial.
    Brorsson AL; Leksell J; Andersson Franko M; Lindholm Olinder A
    Pediatr Diabetes; 2019 Nov; 20(7):986-996. PubMed ID: 31268224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.